Individualized treatment effect of GnRH antagonist versus depot GnRH-a long protocol on cumulative live birth: a causal forest approach

Purpose To balance the benefits and risks of different controlled ovarian stimulation (COS) protocols, we evaluated the individualized treatment effect (ITE) of the GnRH antagonist protocol versus the follicular phase depot GnRH-a long protocol, corresponding to the cumulative live birth rate (CLBR). Methods A retrospective cohort study included 17,571 IVF/ICSI cycles from January 2016 to December 2022. Propensity score matching was performed and a causal forest model was trained to estimate the ITE. SHAP analysis quantified feature contributions, and generalized additive models were used to visualize feature effects. Results In this exploratory analysis, the depot GnRH-a long protocol demonstrated superior treatment effects compared to the antagonist protocol (ITE range: −0.199 to −0.034). However, higher ITE values correlated with increased OHSS incidence in agonist cycles. An exploratory counterfactual analysis suggested that reallocating patients with ITE > −0.115 to the antagonist protocol would reduce CLBR by 6.08 percentage points (64.30% vs. 58.23%) but decrease OHSS rate by 0.31 percentage points (1.61% vs. 1.30%). In the exploratory SHAP analysis, basal estradiol (E2) appeared as the strongest modifier: the antagonist protocol tended to be favored in patients with low basal E2, high BMI, older age, or extreme AMH levels. Conclusions Although confirmation in prospective randomized studies is required, the follicular phase depot GnRH-a long protocol may achieve higher CLBR than the GnRH antagonist protocol and was accompanied by elevated OHSS risk. In this exploratory analysis, the ITE estimates suggested a potential trade-off between CLBR and OHSS risk. Basal E2 may be considered as an additional marker when selecting a controlled ovarian stimulation protocol.

Authors

Institutions

Publication Details

Journal
Frontiers in Reproductive Health
Published
2026-11-16
DOI
https://doi.org/10.3389/frph.2026.1943685
Primary Topic
Reproductive Health and Technologies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Individualized treatment effect of GnRH antagonist versus depot GnRH-a long protocol on cumulative live birth: a causal forest approach

Caihui Ma, Jianzhi Ren, Xuhong Na, Ling Ouyang et al.
Frontiers in Reproductive Health
Reproductive Health and Technologies
article

Individualized treatment effect of GnRH antagonist versus depot GnRH-a long protocol on cumulative live birth: a causal forest approach

Caihui Ma, Jianzhi Ren, Xuhong Na, Ling Ouyang, Jie Geng, Luxiang Pan, Yurong Chen, H D Chen, Xiaoming Jiang, Jiali Cai
article en

Abstract

Purpose To balance the benefits and risks of different controlled ovarian stimulation (COS) protocols, we evaluated the individualized treatment effect (ITE) of the GnRH antagonist protocol versus the follicular phase depot GnRH-a long protocol, corresponding to the cumulative live birth rate (CLBR). Methods A retrospective cohort study included 17,571 IVF/ICSI cycles from January 2016 to December 2022. Propensity score matching was performed and a causal forest model was trained to estimate the ITE. SHAP analysis quantified feature contributions, and generalized additive models were used to visualize feature effects. Results In this exploratory analysis, the depot GnRH-a long protocol demonstrated superior treatment effects compared to the antagonist protocol (ITE range: −0.199 to −0.034). However, higher ITE values correlated with increased OHSS incidence in agonist cycles. An exploratory counterfactual analysis suggested that reallocating patients with ITE > −0.115 to the antagonist protocol would reduce CLBR by 6.08 percentage points (64.30% vs. 58.23%) but decrease OHSS rate by 0.31 percentage points (1.61% vs. 1.30%). In the exploratory SHAP analysis, basal estradiol (E2) appeared as the strongest modifier: the antagonist protocol tended to be favored in patients with low basal E2, high BMI, older age, or extreme AMH levels. Conclusions Although confirmation in prospective randomized studies is required, the follicular phase depot GnRH-a long protocol may achieve higher CLBR than the GnRH antagonist protocol and was accompanied by elevated OHSS risk. In this exploratory analysis, the ITE estimates suggested a potential trade-off between CLBR and OHSS risk. Basal E2 may be considered as an additional marker when selecting a controlled ovarian stimulation protocol.

Frontiers in Reproductive HealthVol. 8
Xiamen University (CN)
Good health and well-being
Reproductive Health and Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon